Long Covid in Year 5: Some Progress, Still Many Questions.
Meagher, Timothy · Journal of insurance medicine (New York, N.Y.) · 2025 · DOI
Quick Summary
Five years after Long Covid was first recognized in 2020, researchers have made progress understanding the condition, but significant challenges remain. While most people's symptoms improve over time, scientists still haven't found reliable blood tests to diagnose it or effective treatments. Long Covid appears to share many similarities with ME/CFS, and the condition can develop or worsen after repeated COVID-19 infections.
Why It Matters
This analysis is critical for ME/CFS patients because it clarifies the relationship between Long Covid and ME/CFS, two conditions with substantial overlap. Understanding the current state of research helps patients recognize what is and isn't known about post-infectious illnesses, and highlights that despite years of study, effective treatments remain absent—underscoring the need for continued research investment.
Observed Findings
Most individuals with Long Covid experience progressive symptom improvement over time
Approximately 20% of affected individuals report symptoms that limit their daily activities
Recurrent COVID-19 infections are now a significant source of new Long Covid cases
Evidence supports the existence of multiple disease endotypes rather than a single mechanism
The anticipated surge in disability insurance claims from Long Covid has not materialized
Inferred Conclusions
Substantial progress has been made in characterizing Long Covid, but fundamental gaps remain in biomarker identification and therapeutic development
Long Covid and ME/CFS demonstrate considerable overlap, suggesting shared post-infectious pathophysiology
The natural history of Long Covid typically favors gradual improvement, though a meaningful minority experience persistent disability
Remaining Questions
What are the underlying biological mechanisms driving Long Covid, and why do some individuals recover while others develop chronic disease?
How can clinicians reliably diagnose Long Covid and ME/CFS in the absence of validated biomarkers?
What This Study Does Not Prove
This editorial does not prove that Long Covid and ME/CFS are identical conditions, only that they share significant overlap. It does not establish definitive disease mechanisms or explain why some individuals recover while others develop persistent disability. The observation that disability claims were lower than anticipated does not prove Long Covid causes minimal disability; it may reflect reporting gaps, insurance barriers, or other confounding factors.